CARA HENNINGS: Open Payments
NPI 1639346448 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,587 in 136 payments from 21 companies in 2025. Trend: 2023 $2,679 · 2024 $3,062 · 2025 $2,587
Food & beverage: $2,587
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 9 | $256 |
| UCB, Inc. | 9 | $219 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 13 | $211 |
| Novartis Pharmaceuticals Corporation | 14 | $202 |
| REVANCE THERAPEUTICS, INC. | 9 | $195 |
| ABBVIE INC. | 13 | $194 |
| Galderma Laboratories, L.P. | 14 | $178 |
| LEO Pharma Inc. | 8 | $166 |
| Amgen Inc. | 9 | $151 |
| Janssen Biotech, Inc. | 6 | $147 |
Products named: DUPIXENT, ILUMYA, DAXXIFY, Bimzelx, COSENTYX, OTEZLA, TREMFYA, EBGLYSS.
Industry payments across TN — which companies pay providers there.
